Carregant...
The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable
In the USA, an interchangeability designation provides biosimilar sponsors with a pathway for achieving what is standard for small-molecule generics: pharmacy-level auto-substitution for an innovator. No other major health authority links interchangeability to automatic substitution, as all require...
Guardat en:
| Publicat a: | Adv Ther |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Healthcare
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8107170/ https://ncbi.nlm.nih.gov/pubmed/33745111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01688-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|